Journal Article Summary
The article investigates how patients in the UK are managed in primary care after episodes of self-harm, a significant concern given that self-harm is a strong predictor of suicide. Understanding the clinical management of these patients is crucial because general practitioners (GPs) play a vital role in assessing and supporting individuals who have harmed themselves. Despite existing guidelines emphasizing the importance of primary care in managing self-harm, there is a lack of research focused on this area, making it essential to explore how these patients are treated in general practice settings.
The study analyzed data from nearly 50,000 patients who had self-harmed, focusing on their treatment within a year following the incident. Key findings revealed that only about 15% of these patients were referred to mental health services, and a significant number were prescribed psychotropic medications without a prior psychiatric diagnosis. Additionally, patients from more deprived areas were less likely to receive referrals, highlighting health inequalities. Alarmingly, despite guidelines against prescribing certain medications due to their toxicity in overdose, nearly 9% of patients were still prescribed tricyclic antidepressants.
The study has limitations, including a lack of data on whether patients followed through with referrals and the absence of information on non-medical treatments. This raises concerns about patient safety, as inadequate management can lead to increased risks of further self-harm or suicide. Readers are encouraged to discuss these findings with healthcare professionals, particularly regarding the importance of appropriate referrals and medication management for individuals who have self-harmed, as well as the need for improved guidelines in primary care settings.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Carr Matthew J., Ashcroft Darren M., Kontopantelis Evangelos, While David, Awenat Yvonne, Cooper Jayne, Chew-Graham Carolyn, Kapur Nav, et al.. Clinical management following self-harm in a UK-wide primary care cohort. Journal of Affective Disorders 2016. DOI: 10.1016/j.jad.2016.03.013. PMID: 26994436. PMCID: PMC4870375.
Featured Pill Pals Product
Citalopram 10 mg Tablets --- Generic For Celexa --- Mylan
Citalopram 10 mg Tablets — Generic For Celexa — Mylan is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
